From Breslow to BRAF and immunotherapy: evolving concepts in melanoma pathogenesis and disease progression and their implications for changing management over the last 50 years
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 95, 149-160
Abstract
No abstract availableKeywords
Funding Information
- MIA
- NHMRC
This publication has 76 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaNature Genetics, 2012
- The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of originPigment Cell & Melanoma Research, 2011
- BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor sitePigment Cell & Melanoma Research, 2011
- Genetic and morphologic features for melanoma classificationPigment Cell & Melanoma Research, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Mutations of the BRAF gene in human cancerNature, 2002
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992